| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Amberjack Capital Partners, L.P. | Director, 10%+ Owner | 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON | AMBERJACK CAPITAL PARTNERS, L.P., By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Managing Partner | 27 Feb 2026 | 0002026035 |
| Amberjack Capital Associates II, LLC | Director, 10%+ Owner | 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON | AMBERJACK CAPITAL FUND II, L.P., By: Amberjack Capital GP II, L.P., its general partner, By: Amberjack Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner | 27 Feb 2026 | 0002026029 |
| Amberjack Capital Fund II, L.P. | Director, 10%+ Owner | 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON | AMBERJACK CAPITAL GP II, L.P., By: Amberjack Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner | 27 Feb 2026 | 0001944811 |
| Amberjack Capital GP II, L.P. | Director, 10%+ Owner | 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON | AMBERJACK CAPITAL ASSOCIATES II, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner | 27 Feb 2026 | 0002026032 |
| Innovex Co-Invest Associates, LLC | Director, 10%+ Owner | 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON | AMBERJACK MANAGEMENT, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner | 27 Feb 2026 | 0002026027 |
| Innovex Co-Invest Fund II GP, L.P. | Director, 10%+ Owner | 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON | JASON TUROWSKY, /s/ Jason Turowsky | 27 Feb 2026 | 0002026028 |
| Innovex Co-Invest Fund II, L.P. | Director, 10%+ Owner | 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON | INNOVEX CO-INVEST FUND II, L.P., By: Innovex Co-Invest Fund II GP, L.P., its general partner, By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner | 27 Feb 2026 | 0001958403 |
| Turowsky Jason | Director, 10%+ Owner | 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON | INNOVEX CO-INVEST FUND II GP, L.P., By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner | 27 Feb 2026 | 0002025157 |
| Amberjack Management, LLC | Director, 10%+ Owner | 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON | INNOVEX CO-INVEST ASSOCIATES, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner | 27 Feb 2026 | 0002026020 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INVX | Common Stock | Sale | $120,552,553 | -4,902,244 | -23% | $24.59 | 16,871,374 | 27 Feb 2026 | By Amberjack Capital Fund II, L.P. | F1, F7, F8, F9, F10 |
| transaction | INVX | Common Stock | Sale | $28,148,063 | -1,144,635 | -23% | $24.59 | 3,939,330 | 27 Feb 2026 | By Innovex Co-Invest Fund II, L.P. | F2, F7, F8, F9, F10 |
| transaction | INVX | Common Stock | Sale | $6,671,103 | -271,279 | -23% | $24.59 | 933,624 | 27 Feb 2026 | By Innovex Co-Invest Fund, L.P. | F3, F7, F8, F9, F10 |
| transaction | INVX | Common Stock | Sale | $5,754,586 | -234,009 | -23% | $24.59 | 805,355 | 27 Feb 2026 | By Intervale Capital Fund II, L.P. | F4, F7, F8, F9, F10 |
| transaction | INVX | Common Stock | Sale | $2,853 | -116 | -23% | $24.59 | 399 | 27 Feb 2026 | By Intervale Capital Fund II-A, L.P. | F5, F7, F8, F9, F10 |
| transaction | INVX | Common Stock | Sale | $1,480,814 | -60,217 | -23% | $24.59 | 207,240 | 27 Feb 2026 | By Intervale Capital Fund III, L.P. | F6, F7, F8, F9, F10 |
| Id | Content |
|---|---|
| F1 | Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to the public of $25.75 per share. Amberjack Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts. |
| F2 | Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts. |
| F3 | Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts. |
| F4 | Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts. |
| F5 | Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II-A, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts. |
| F6 | Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund III, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts. |
| F7 | The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC. |
| F8 | (Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds". |
| F9 | By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management. |
| F10 | (Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities. |
This Form 4 is the second of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. The first of two Forms 4 was filed by the designated filer Innovex Co-Invest Fund, L.P.